Pathology Home Page

Pathology House Officers

Pathology Fellowships

Medical Technology

Training Opportunities

Graduate Programs

Laboratory Services

Faculty Home Pages

MW Beaty MD

S Bergman MD

JO Cappellari MD

SR Feldman MD PhD

AJ Garvin MD PhD

KR Geisinger MD

KG Gibson MD

DD Grier MD

S Iskandar MBBCh PhD

DR Jason MD JD

TE Kute PhD

PE Lantz MD

J Laudadio MD

RT Mott MD

EL Palavecino MD

GJ Pomper MD

SJ Sirintrapun MD

CS Pang MD

SA Qasem MD

OP Sangueza MD

ZK Shihabi PhD

MB Simpson MD

CA Stanton MD

MW Willingham MD

All Pathology Dept. Faculty

Comparative Medicine Home

Lipid Sciences Home

Tumor Biology Home

Cancer-Resistant Mice

All Pathology Dept. Faculty

About Winston-Salem, NC

Alumni News

Internal Access Only

WFUBMC Home

>

Pathology

>

Faculty Home Pages

>

EL Palavecino MD

Elizabeth L. Palavecino, MD Associate Professor of Pathology (Clinical Pathology) Director: Clinical Microbiology Board Certification: American Board of Pathology: Clinical Pathology Education: Undergraduate: Universidad de Chile, Santiago Postgraduate: Universidad de Chile, MD 1980 Residency: University Hospitals of Cleveland, 2001 Fellowships: University of Minnesota Hospitals, 1992; University Hospitals of Cleveland, 2002 Interests: Teaching: Microbiology, Laboratory Diagnosis Research: Antimicrobial susceptibility testing, mechanisms of resistance to antimicrobial agents, laboratory testing Clinical: Microbiology, Molecular Diagnosis Dr. Elizabeth Palavecino Tel: (336) 716-2638 Fax: (336) 716-7595 epalave@wfubmc.edu   Recent Publications: Grier DD, Lewis Z, Palavecino EL. Bone marrow involvement by Pneumocystis jiroveci. Br J Haematol. 2009 Apr;145(2):149. Coldren FM, Palavecino EL, Levi-Polyachenko NH, Wagner WD, Smith TL, Smith BP, Webb LX, Carroll DL. Encapsulated Staphylococcus aureus strains vary in adhesiveness assessed by atomic force microscopy. J Biomed Mater Res A. 2008 Apr 22. [Epub ahead of print] Lin SS, Pranikoff T, Smith SF, Brandt ME, Gilbert K, Palavecino EL, Shetty AK. Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome. J Med Microbiol. 2008 Apr;57(Pt 4):516-8. Palavecino EL, Yomtovian RA, Jacobs MR. Detecting bacterial contamination in platelet products. Clin Lab. 2006;52(9-10):443-56. Yomtovian RA, Palavecino EL, Dysktra AH, Downes KA, Morrissey AM, Bajaksouzian S, Pokorny MA, Lazarus HM, Jacobs MR. Evolution of surveillance methods for detection of bacterial contamination of platelets in a university hospital, 1991 through 2004. Transfusion. 2006 May;46(5):719-30. Jacobs MR, Bajaksouzian S, Windau A, Palavecino EL, Yomtovian R. Evaluation of the Scansystem method for detection of bacterially contaminated platelets. Transfusion. 2005 Feb;45(2):265-9. Palavecino E, Jacobs M, Yomtovian R. Bacterial contamination of blood products. Curr Hematol Rep. 2004 Nov;3(6):450-5. Froberg MK, Palavecino E, Dykoski R, Gerding DN, Peterson LR, Johnson S. Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases. Clin Infect Dis. 2004 Sep 1;39(5):747-50. Palavecino E. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin Lab Med. 2004 Jun;24(2):403-18. Review. Palavecino E, Yomtovian R. Risk and prevention of transfusion-related sepsis. Curr Opin Hematol. 2003 Nov;10(6):434-439. Tapia C, Gonzalez P, Pereira A, Perez J, Noriega LM, Palavecino E. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest]. Rev Med Chil. 2003 May;131(5):515-9. Spanish. Roy S, Schreiber JR, John CC, Kaplan EL, Rodriguez B, Salata RA, Palavecino E. A family cluster of five cases of group a streptococcal pneumonia. Pediatrics. 2003 Jul;112(1 Pt 1):e61-5. Tapia C, Leon E, Palavecino E. [Antifungal susceptibility of yeasts by Etest. Comparison of 3 media] Rev Med Chil. 2003 Mar;131(3):299-302. Spanish. Palavecino EL, Riedel I, Duran C, Bajaksouzian S, Joloba M, Davies T, Appelbaum PC, Jacobs MR. Macrolide resistance phenotypes in Streptococcus pneumoniae in Santiago, Chile. Int J Antimicrob Agents. 2002 Aug;20(2):108-12. Garcia P, Levican J, Quiroga T, Montiel F, Palavecino E. Direct identification of Staphylococcus aureus from positive blood culture specimens with a rapid test. J Med Microbiol. 2002 Jun;51(6):530-1. Lopez-Vidal Y, Palavecino E, Rossi F; Latin American Surveillance and Epidemiology Research (LASER) Study Group. Prevalence of beta-lactamase production in H. influenzae isolated in Latin America in 1998-1999: results of the LASER study. Int J Antimicrob Agents. 2002 Mar;19(3):201-5. Palavecino EL. Recommendations on the susceptibility testing of Staphylococcus aureus, Coagulase negative staphylococci and S. saprophyticus: New breakpoints and interpretation of results. Rev Chil Infectol. 2002; Supplement 2: S119-124. Jacobs MR, Palavecino E, Yomtovian R. Don't bug me: the problem of bacterial contamination of blood components--challenges and solutions. Transfusion. 2001 Nov;41(11):1331-4. Review. Nagai K, Davies TA, Ednie LM, Bryskier A, Palavecino E, Jacobs MR, Appelbaum PC. Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes. Antimicrob Agents Chemother. 2001 Nov;45(11):3242-5. Palavecino EL. The crisis of resistant pathogens in respiratory tract infections--use of pharmacodynamic principles. Am J Manag Care. 2001 Jun;7(6 Suppl):S170-7. Review. Palavecino EL, Riedel I, Berrios X, Bajaksouzian S, Johnson D, Kaplan E, Jacobs MR. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother. 2001 Jan;45(1):339-41.